May 15, 2020
Contracting and treating COVID-19 can be worrisome for people with diabetes, with this in mind, Eli Lilly and Company and Beyond Type 1, a diabetes advocacy group, are working to ensure that people living with diabetes are prepared to manage their condition throughout the COVID-19 pandemic. My guests are Andy Vicari, Senior Director & U.S. Brand Leader, Insulins, Eli Lilly and Company and Dr. Anne Peters, Beyond Type 1 Science Advisory Committee.